Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB) -- Ignore unavailable to you. Want to Upgrade?

To: james paterson who wrote (56)	7/28/1998 4:12:00 PM
From: Heat Shock	Read Replies (1) \| Respond to of 236

James, The following back-of-the-envelope calculation justifies a share price of around 2.65. When the new financing announcement came out recently, we learned that the number of shares of SSB outstanding will (over the next 5 years) go from about 27 million to about 35 million. At 3.30 a share, 27 million shares gives a market cap of around $92 million. If we assume there is immediately 35 million shares (not over 5 years), the share price would be around 2.65. Sure enough, the share price fell into that 2.65 neighbourhood. I'm guessing the current dip is low volume noise. The volume today was a picayune 3,972 shares. Heat.